The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloid derived suppressor cells (MDSC) and inflammatory biomarkers in metastatic urothelial carcinoma (mUC).
 
Moshe Chaim Ornstein
No Relationships to Disclose
 
C. Marcela Diaz-Montero
No Relationships to Disclose
 
Patricia A. Rayman
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Samuel Haywood
No Relationships to Disclose
 
Jin Sub Kim
No Relationships to Disclose
 
Paul G Pavicic
No Relationships to Disclose
 
James Finke
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Andrew J. Stephenson
No Relationships to Disclose
 
Marcelo Lamenza
No Relationships to Disclose
 
Priscilla Dann
No Relationships to Disclose
 
Kim Schach
No Relationships to Disclose
 
Sarah Devonshire
No Relationships to Disclose
 
Jennifer S Ko
No Relationships to Disclose
 
Amr Farouk Fergany
No Relationships to Disclose
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Celyad; Omniseq
Research Funding - Alkermes; Altor BioScience; Bristol-Myers Squibb; Merck
 
Christopher J. Hoimes
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Merck Sharp & Dohme
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech; Merck
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)